![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2020
Ilhan, Harun; Lindner, S.; Todica, A.; Cyran, C. C.; Tiling, R.; Auernhammer, C. J.; Spitzweg, C.; Boeck, S.; Unterrainer, M.; Gildehaus, F. J.; Böning, G.; Jurkschat, K.; Wängler, C.; Wängler, B.; Schirrmacher, R. und Bartenstein, P.
(2020):
Biodistribution and first clinical results of F-18-SiFAlin-TATE PET: a novel F-18-labeled somatostatin analog for imaging of neuroendocrine tumors.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 47, Nr. 4: S. 870-880
2016
Hartenbach, M.; Weber, S.; Hartenbach, S.; Zacherl, M.; Papprottka, P. M.; Tiling, R.; Bartenstein, P.; Hacker, M.; Albert, Nathalie L. 
ORCID: https://orcid.org/0000-0003-0953-7624 und Haug, A.
(2016):
Prognoctic value of combined [(99m)]Tc-MAA-SPECT/CT and [F-18]Fluorethylcholine-PET/CT in patients suffering from advanced hepatocellular carcinoma prior to radioembolization.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 43:
S17-S17
ORCID: https://orcid.org/0000-0003-0953-7624 und Haug, A.
(2016):
Prognoctic value of combined [(99m)]Tc-MAA-SPECT/CT and [F-18]Fluorethylcholine-PET/CT in patients suffering from advanced hepatocellular carcinoma prior to radioembolization.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 43:
S17-S17
2003
Tiling, R.; Keßler, M.; Untch, M.; Sommer, H.; Linke, R.; Brinkbäumer, K. und Hahn, K.
(2003):
Breast cancer: Monitoring response to neoadjuvant chemotherapy using Tc-99m sestamibi scintimammography.
In: Onkologie, Nr. 1: S. 27-31
[PDF, 133kB]